REPROCELL USA Inc. Achieves Quality Management ISO9001:2015 Certification
08 April 2019
Find out about REPROCELL USA's recently achieved ISO9001:2015 accreditation. demonstrating its ability to consistently meet customer requirements
REPROCELL Inc. forms joint venture with Fox Chase Cancer Center to begin operations on biosample repositories
28 February 2019
REPROCELL Inc. and Fox Chase, Ltd., have formed a joint venture to begin operations of multi-site biosample repository facilities globally.
Human Tissue Experts REPROCELL Launch New Customized Primary Cell Isolation Services
21 June 2018
Read more about how REPROCELL’s BioServe and Biopta tissue procurement networks have combined to create a new service isolating human primary cells.
REPROCELL and Fox Chase Cancer Center Partner to Open Multi-Site Biosample Repository in India
24 May 2017
REPROCELL and Fox Chase Cancer Center today announced a joint venture to open a multi-site bio-sample repository facility in India.
REPROCELL and Fox Chase Cancer Center Form Strategic Alliance to Accelerate Biomarker and Genetic Discovery
13 April 2017
REPROCELL and Fox Chase Cancer Center have announced a strategic alliance aimed at accelerating oncology discovery and translational studies, read more